← Leaderboards
Paul N. Epstein
University Of North Dakota
$8,312,041
Attributed
$8,312,041
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$8,627,379 · 8
By mechanism
R01$7,878,518 · 6
R21$433,523 · 1
S10$315,338 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Dakota
Same institution · by research overlap
- Ke Kurt Zhang$1,715,821
Others in their field
Top investigators on “Antioxidants”
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$31,629,832
- Merit E Cudkowicz · Massachusetts General Hospital$31,059,060
- John James McNeil · Hennepin Healthcare Research Institute$28,037,648
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$25,007,335
- Habibul Ahsan · Columbia University Health Sciences$21,519,304
- Michael A Schwarzschild · Massachusetts General Hospital$20,511,375
Research focus
AntioxidantsDiabetes MellitusGenetically Modified AnimalsLaboratory MouseGene ExpressionSuperoxide DismutaseMetallothioneinCatalaseFree Radical OxygenGlucose MetabolismAnimalsDisease /Disorder ModelMouse ModelPancreatic IsletsHeart ContractionProteinsCell TypeChronicMorphologyLight MicroscopyDiabetic MouseExhibitsMyocardial Ischemia /HypoxiaDiabetic
Grant awards (35)
Can low blood glucose extend health$234,643
R21 · FY2017 · AG · contact PI
Can low blood glucose extend health$198,880
R21 · FY2016 · AG · contact PI
Prolonged Diabetic Damage to Cardiac Mitochondria$100,000
R01 · FY2010 · DK · contact PI
Podocytes and oxidative stress in diabetic kidney$96,950
R01 · FY2010 · DK · contact PI
Prolonged Diabetic Damage to Cardiac Mitochondria$341,313
R01 · FY2009 · DK · contact PI
Podocytes and oxidative stress in diabetic kidney$320,999
R01 · FY2009 · DK · contact PI
Prolonged Diabetic Damage to Cardiac Mitochondria$341,313
R01 · FY2008 · DK · contact PI
Podocytes and oxidative stress in diabetic kidney$320,999
R01 · FY2008 · DK · contact PI
Prolonged Diabetic Damage to Cardiac Mitochondria$348,278
R01 · FY2007 · DK · contact PI
Podocytes and oxidative stress in diabetic kidney$327,550
R01 · FY2007 · DK · contact PI
Prolonged Diabetic Damage to Cardiac Mitochondria$358,680
R01 · FY2006 · DK · contact PI
Podocytes and oxidative stress in diabetic kidney$337,333
R01 · FY2006 · DK · contact PI
Altered glucose homeostasis by sleep impairment$322,978
R01 · FY2006 · HL · contact PI
Antioxidant transgene in diabetic cardiomyopathy$287,091
R01 · FY2006 · HL · contact PI
Podocytes and oxidative stress in diabetic kidney$345,450
R01 · FY2005 · DK
Altered glucose homeostasis by sleep impairment$330,750
R01 · FY2005 · HL
Antioxidant transgene in diabetic cardiomyopathy$294,000
R01 · FY2005 · HL
Altered glucose homeostasis by sleep impairment$330,750
R01 · FY2004 · HL
Laser Scanning Confocal Microscope$315,338
S10 · FY2004 · RR
Antioxidant transgene in diabetic cardiomyopathy$294,000
R01 · FY2004 · HL
Altered glucose homeostasis by sleep impairment$329,019
R01 · FY2003 · HL
Antioxidant transgene in diabetic cardiomyopathy$292,000
R01 · FY2003 · HL
REDUCING DIABETIC CARDIOMYOPATHY: INCREASING GLYCOLYSIS$248,037
R01 · FY2003 · HL
BETA-CELL ANTIOXIDANT TRANSGENES IN DIABETES TRANSPLANT.$180,000
R01 · FY2003 · DK
REDUCING DIABETIC CARDIOMYOPATHY: INCREASING GLYCOLYSIS$248,037
R01 · FY2002 · HL
BETA-CELL ANTIOXIDANT TRANSGENES IN DIABETES TRANSPLANT.$180,000
R01 · FY2002 · DK
REDUCING DIABETIC CARDIOMYOPATHY: INCREASING GLYCOLYSIS$248,037
R01 · FY2001 · HL
ANTIOXIDANT TRANSGENES IN DIABETIC CARDIOMYOPATHY$240,880
R01 · FY2001 · HL
BETA-CELL ANTIOXIDANT TRANSGENES IN DIABETES TRANSPLANT.$180,000
R01 · FY2001 · DK
REDUCING DIABETIC CARDIOMYOPATHY: INCREASING GLYCOLYSIS$16,019
R01 · FY2001 · HL
REDUCING DIABETIC CARDIOMYOPATHY: INCREASING GLYCOLYSIS$211,950
R01 · FY2000 · HL
ANTIOXIDANT TRANSGENES IN DIABETIC CARDIOMYOPATHY$177,400
R01 · FY2000 · HL
BETA-CELL ANTIOXIDANT TRANSGENES IN DIABETES TRANSPLANT.$170,550
R01 · FY2000 · DK
ANTIOXIDANT TRANSGENES IN DIABETIC CARDIOMYOPATHY$52,080
R01 · FY2000 · HL
BETA-CELL ANTIOXIDANT TRANSGENES IN DIABETES TRANSPLANT.$6,075
R01 · FY2000 · DK